Stock PRTG PORTAGE BIOTECH INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Portage Biotech Inc.

Equities

PRTG

VGG7185A1286

Market Closed - Nasdaq
Other stock markets
 02:00:00 04/05/2024 am IST 		5-day change 1st Jan Change
0.271 USD +4.27% Intraday chart for Portage Biotech Inc. +12.82% -85.11%
15/04 Portage Biotech Announces Plans to Expand Its Evaluation of Strategic Alternatives CI
12/04 Portage Biotech Announces Plans to Expand Its Evaluation of Strategic Alternatives CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Portage Biotech : Director Resignations - Form 6-K
PU
Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives-Adenosine clinical development paused
AQ
Portage biotech announces plans to expand its evaluation of strategic alternatives
AQ
Portage Biotech Announces Plans to Expand Its Evaluation of Strategic Alternatives
CI
Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives
AQ
Portage Biotech Announces Plans to Expand Its Evaluation of Strategic Alternatives
CI
Portage biotech completes monetization of intensity therapeutics shares
AQ
Portage Biotech Completes Monetization of Intensity Therapeutics (INTS) shares
AQ
Portage Biotech : Corporate Presentation - March 2024
PU
Portage Biotech Reports Results for Fiscal Quarter Ended December 31, 2023, and Business Update
AQ
Portage Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
HC Wainwright Downgrades Portage Biotech to Neutral From Buy
MT
Portage Biotech to Pause Drug Development in PORT-2 iNKT Program, to Cut Workforce
MT
Portage Biotech to Evaluate Range of Strategic Options
CI
Portage Biotech Reports Business and Strategic Update
AQ
Portage Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
CI
Portage Biotech Reports Results for Fiscal Quarter Ended June 30, 2023, and Business Update
AQ
Portage biotech presents updates on its inkt and adenosine programs at the society for immunotherapy of cancer's 38th annual meeting
AQ
Portage Biotech Presents Updates on its iNKT and Adenosine programs at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting
AQ
Portage Biotech Inc. Presents Updates on its iNKT and Adenosine Programs at the Society for Immunotherapy of Cancer's 38th Annual Meeting
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PRTG Stock
  4. News Portage Biotech Inc.